Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-27

Clinical Trial Update: Hysteroscopic Lymphatic Mapping for Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating hysteroscopic lymphatic mapping for endometrial cancer was terminated, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Endometrial Cancer | Phase 2 | Status: TERMINATED | Results posted: 2011-07-27